GT Biopharma, Inc. (GTBP) earnings
Quarterly results of GT Biopharma, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
GT Biopharma, Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) GT Biopharma, Inc. reported revenue of - and a net loss of $4.5M.
Diluted earnings per share were -$0.12.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$4.5M | -$0.12 |
| Q1 FY2026 | - | - | -$2.8M | -$0.11 |
| Q4 FY2025 | - | - | -$5.7M | - |
| Q3 FY2025 | - | - | $8.3M | $1.04 |
| Q2 FY2025 | - | - | -$30.2M | -$10.92 |
| Q1 FY2025 | - | - | -$776K | -$0.33 |
| Q4 FY2024 | - | - | -$3.8M | - |
| Q3 FY2024 | - | - | -$3.4M | -$1.53 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Quarterly report (amended) 10-Q/A
- Quarterly report (amended) 10-Q/A
- Annual report 10-K
When is GT Biopharma, Inc.'s next earnings date?
GT Biopharma, Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Get an email when GTBP reports
Follow GTBP and we email you its next results the day they are filed, with the numbers explained.